Document Detail


The action of cytochrome b(5) on CYP2E1 and CYP2C19 activities requires anionic residues D58 and D65.
MedLine Citation:
PMID:  23193974     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The capacity of cytochrome b(5) (b(5)) to influence cytochrome P450 activities has been extensively studied and physiologically validated. Apo-b(5) enhances the activities of CYP3A4, CYP2A6, CYP2C19, and CYP17A1 but not that of CYP2E1 or CYP2D6, suggesting that the b(5) interaction varies among P450s. We previously showed that b(5) residues E48 and E49 are required to stimulate the 17,20-lyase activity of CYP17A1, but these same residues might not mediate b(5) activation of other P450 reactions, such as CYP2E1-catalyzed oxygenations, which are insensitive to apo-b(5). Using purified P450, b(5), and reductase (POR) in reconstituted assays, the D58G/D65G double mutation, of residues located in a hydrophilic α-helix of b(5), totally abolished the ability to stimulate CYP2E1-catalyzed chlorzoxazone 6-hydroxylation. In sharp contrast, the D58G/D65G double mutation retained the full ability to stimulate the 17,20-lyase activity of CYP17A1. The D58G/D65G double mutation competes poorly with wild-type b(5) for binding to the CYP2E1·POR complex yet accepts electrons from POR at a similar rate. Furthermore, the phospholipid composition markedly influences P450 turnover and b(5) stimulation and specificity, particularly for CYP17A1, in the following order: phosphatidylserine > phosphatidylethanolamine > phosphatidylcholine. The D58G/D65G double mutation also failed to stimulate CYP2C19-catalyzed (S)-mephenytoin 4-hydroxylation, whereas the E48G/E49G double mutation stimulated these activities of CYP2C19 and CYP2E1 equivalent to wild-type b(5). We conclude that b(5) residues D58 and D65 are essential for the stimulation of CYP2E1 and CYP2C19 activities and that the phospholipid composition significantly influences the b(5)-P450 interaction. At least two surfaces of b(5) differentially influence P450 activities, and the critical residues for individual P450 reactions cannot be predicted from sensitivity to apo-b(5) alone.
Authors:
Hwei-Ming Peng; Richard J Auchus
Related Documents :
22937904 - Computational analysis of human oga structure in complex with pugnac and nag-thiazoline...
24061234 - Review of the catalytic voltammetric determination of titanium traces.
23522154 - Fluorometric immunocapture assay for the specific measurement of matrix metalloproteina...
24344244 - Protonation controls asic1a activity via coordinated movements in multiple domains.
9596584 - X-ray crystal structure of c3d: a c3 fragment and ligand for complement receptor 2.
12044884 - A putative nuclear receptor coactivator (tmf/ara160) associates with hbrm/hsnf2 alpha a...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2012-12-17
Journal Detail:
Title:  Biochemistry     Volume:  52     ISSN:  1520-4995     ISO Abbreviation:  Biochemistry     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-01-08     Completed Date:  2013-03-05     Revised Date:  2014-03-10    
Medline Journal Info:
Nlm Unique ID:  0370623     Medline TA:  Biochemistry     Country:  United States    
Other Details:
Languages:  eng     Pagination:  210-20     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aryl Hydrocarbon Hydroxylases / metabolism*
Chlorzoxazone / metabolism
Cytochrome P-450 CYP2E1 / metabolism*
Cytochromes b5 / chemistry*,  genetics,  metabolism*
Humans
Hydroxylation
Mephenytoin / metabolism
Models, Molecular
Muscle Relaxants, Central / metabolism
NADP / metabolism
Oxidoreductases Acting on CH-CH Group Donors / metabolism
Phospholipids / metabolism
Point Mutation
Progesterone / metabolism
Grant Support
ID/Acronym/Agency:
R01 GM086596/GM/NIGMS NIH HHS; R01-GM08659602/GM/NIGMS NIH HHS
Chemical
Reg. No./Substance:
0/Muscle Relaxants, Central; 0/Phospholipids; 4G7DS2Q64Y/Progesterone; 53-59-8/NADP; 9035-39-6/Cytochromes b5; EC 1.14.14.1/Aryl Hydrocarbon Hydroxylases; EC 1.14.14.1/CYP2C19 protein, human; EC 1.14.14.1/Cytochrome P-450 CYP2E1; EC 1.3.-/Oxidoreductases Acting on CH-CH Group Donors; EC 1.3.1.33/protochlorophyllide reductase; H0DE420U8G/Chlorzoxazone; R420KW629U/Mephenytoin
Comments/Corrections
Erratum In:
Biochemistry. 2014 Jan 28;53(3):610

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Structure of the O-Specific Polysaccharide from the Lipopolysaccharide of Psychrobacter cryohalolent...
Next Document:  Mechanistic Insights into Enantioselective Gold-Catalyzed Allylation of Indoles with Alcohols: the C...